151 related articles for article (PubMed ID: 9329355)
1. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.
Hwu CM; Kwok CF; Lai TY; Shih KC; Lee TS; Hsiao LC; Lee SH; Fang VS; Ho LT
J Clin Endocrinol Metab; 1997 Oct; 82(10):3285-92. PubMed ID: 9329355
[TBL] [Abstract][Full Text] [Related]
2. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
Nørrelund H; Vahl N; Juul A; Møller N; Alberti KG; Skakkebaek NE; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
[TBL] [Abstract][Full Text] [Related]
4. Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function.
Jørgensen JO; Nørrelund H; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1355-60. PubMed ID: 12510991
[TBL] [Abstract][Full Text] [Related]
5. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
[TBL] [Abstract][Full Text] [Related]
6. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.
Svensson J; Fowelin J; Landin K; Bengtsson BA; Johansson JO
J Clin Endocrinol Metab; 2002 May; 87(5):2121-7. PubMed ID: 11994351
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL
J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
[TBL] [Abstract][Full Text] [Related]
8. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
9. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
[TBL] [Abstract][Full Text] [Related]
10. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
[TBL] [Abstract][Full Text] [Related]
11. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
13. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement.
Ahmad AM; Guzder R; Wallace AM; Thomas J; Fraser WD; Vora JP
J Clin Endocrinol Metab; 2001 Aug; 86(8):3499-506. PubMed ID: 11502770
[TBL] [Abstract][Full Text] [Related]
14. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
15. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
[TBL] [Abstract][Full Text] [Related]
16. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
17. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
[TBL] [Abstract][Full Text] [Related]
18. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450
[TBL] [Abstract][Full Text] [Related]
19. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
